151 related articles for article (PubMed ID: 20412019)
1. Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
Choi HJ; Song JH; Lim CH; Baek SH; Kwon DH
J Med Food; 2010 Apr; 13(2):326-8. PubMed ID: 20412019
[TBL] [Abstract][Full Text] [Related]
2. Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity.
Choi HJ; Song JH; Bhatt LR; Baek SH
Phytother Res; 2010 Sep; 24(9):1292-6. PubMed ID: 20104501
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses.
Choi HJ; Lim CH; Song JH; Baek SH; Kwon DH
Phytomedicine; 2009 Jan; 16(1):35-9. PubMed ID: 19097770
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication.
Choi HJ; Bae EY; Song JH; Baek SH; Kwon DH
Lett Appl Microbiol; 2010 Jul; 51(1):1-5. PubMed ID: 20497313
[TBL] [Abstract][Full Text] [Related]
5. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa.
Song JH; Park KS; Kwon DH; Choi HJ
J Med Food; 2013 Apr; 16(4):274-9. PubMed ID: 23566054
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses.
Park SW; Kwon MJ; Yoo JY; Choi HJ; Ahn YJ
BMC Complement Altern Med; 2014 May; 14():171. PubMed ID: 24885569
[TBL] [Abstract][Full Text] [Related]
7. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
8. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
Ledford RM; Collett MS; Pevear DC
Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
[TBL] [Abstract][Full Text] [Related]
9. Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro.
Cagno V; Civra A; Kumar R; Pradhan S; Donalisio M; Sinha BN; Ghosh M; Lembo D
J Ethnopharmacol; 2015 Dec; 176():252-7. PubMed ID: 26528588
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Kaiser L; Crump CE; Hayden FG
Antiviral Res; 2000 Sep; 47(3):215-20. PubMed ID: 10974374
[TBL] [Abstract][Full Text] [Related]
11. Iota-Carrageenan is a potent inhibitor of rhinovirus infection.
Grassauer A; Weinmuellner R; Meier C; Pretsch A; Prieschl-Grassauer E; Unger H
Virol J; 2008 Sep; 5():107. PubMed ID: 18817582
[TBL] [Abstract][Full Text] [Related]
12. Antiviral and anticancer activities of 13(E)-labd-13-ene-8alpha,15-diol isolated from Brachyglottis monroi.
Choi HJ; Song JH; Kwon DH; Baek SH
Phytother Res; 2010 Feb; 24(2):169-74. PubMed ID: 19504469
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses.
Ngan LT; Jang MJ; Kwon MJ; Ahn YJ
PLoS One; 2015; 10(4):e0121629. PubMed ID: 25860871
[TBL] [Abstract][Full Text] [Related]
14. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
15. Understanding human rhinovirus infections in terms of QSAR.
Verma RP; Hansch C
Virology; 2007 Mar; 359(1):152-61. PubMed ID: 17045322
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
[TBL] [Abstract][Full Text] [Related]
17. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses.
Pevear DC; Hayden FG; Demenczuk TM; Barone LR; McKinlay MA; Collett MS
Antimicrob Agents Chemother; 2005 Nov; 49(11):4492-9. PubMed ID: 16251287
[TBL] [Abstract][Full Text] [Related]
18. The treatment of rhinovirus infections: progress and potential.
Turner RB
Antiviral Res; 2001 Jan; 49(1):1-14. PubMed ID: 11166856
[TBL] [Abstract][Full Text] [Related]
19. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy for enteroviruses and rhinoviruses.
Rotbart HA
Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
